Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cadranel

Showing results (681-690 of 709) with videos related to

Pageof 71
Sort By:
Annals of Hepatology|May 23, 2019
Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting AntiviralsAlexandre Pariente, Jean-Pierre Arpurt, Andre-Jean Remy, et al.
Lancet (London, England)|January 19, 2016
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)Fabrice Barlesi, Julien Mazieres, Jean-Philippe Merlio, et al.
Clinical Lung Cancer|August 12, 2025
AFSOS-SFRO Guidelines on Radiation-Induced Lung InjuryO Cravereau, V Bourbonne, L Vaugier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 7, 2025
[Recommendations on the prevention and management of radiation-induced lung injury from the Association francophone pour les soins oncologiques de support and the Société française de radiothérapie oncologique]Olivier Cravéreau, Vincent Bourbonne, Loïg Vaugier, et al.
Clinics and Research in Hepatology and Gastroenterology|May 20, 2026
Management of severe acute alcoholic hepatitis in France: results of a national survey: R1J F D Cadranel, H T Zougmoré, T Thévenot, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2023
Diagnosis and management of hepatic encephalopathy: The French recommendationsDominique Thabut, Charlotte Bouzbib, Lucy Meunier, et al.
The European Respiratory Journal|May 25, 2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trialJulie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 9, 2025
Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLCBaptiste Abbar, Karim Labreche, Jacques Cadranel, et al.
Nature Medicine|October 26, 2023
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2025
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH studyF de Marinis, T M Kim, L Bonanno, et al.
Pageof 71

Showing results (681-690 of 709) with videos related to

Sort By:
Pageof 71
Annals of Hepatology|May 23, 2019
Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting AntiviralsAlexandre Pariente, Jean-Pierre Arpurt, Andre-Jean Remy, et al.
Lancet (London, England)|January 19, 2016
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)Fabrice Barlesi, Julien Mazieres, Jean-Philippe Merlio, et al.
Clinical Lung Cancer|August 12, 2025
AFSOS-SFRO Guidelines on Radiation-Induced Lung InjuryO Cravereau, V Bourbonne, L Vaugier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 7, 2025
[Recommendations on the prevention and management of radiation-induced lung injury from the Association francophone pour les soins oncologiques de support and the Société française de radiothérapie oncologique]Olivier Cravéreau, Vincent Bourbonne, Loïg Vaugier, et al.
Clinics and Research in Hepatology and Gastroenterology|May 20, 2026
Management of severe acute alcoholic hepatitis in France: results of a national survey: R1J F D Cadranel, H T Zougmoré, T Thévenot, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2023
Diagnosis and management of hepatic encephalopathy: The French recommendationsDominique Thabut, Charlotte Bouzbib, Lucy Meunier, et al.
The European Respiratory Journal|May 25, 2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trialJulie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 9, 2025
Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLCBaptiste Abbar, Karim Labreche, Jacques Cadranel, et al.
Nature Medicine|October 26, 2023
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2025
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH studyF de Marinis, T M Kim, L Bonanno, et al.
Pageof 71